The liver displays a unique ability to grow and regenerate. For example, complete hepatic regeneration occurs within days to weeks after two-thirds of the liver has been resected. Chronic hepatocellular damage can lead to impaired regulation of liver regeneration, which results in hepatocellular carcinoma, one of the most common malignancies in the world. The hypothesis of the parent grant is that HGF, via c-met, regulates growth in the liver by inducing InsP3-mediated Ca2+ signals within the nucleus of hepatocytes. This FIRCA application would investigate whether this is a more general mechanism of action of receptor tyrosine kinases (RTKs) across a range of tissues. Specifically, the hypothesis of this FIRCA application is that the Epidermal Growth Factor receptor (EGFR), like c-met, regulates cell growth by inducing InsP3-mediated Ca2+ signals within the nucleus, and that this action of EGFR mediates cell proliferation in common malignancies. This hypothesis will be tested through the following specific aims: 1. whether and how the EGFR reaches the nucleus in common malignancies will be determined. We will test whether a sub-population of EGFRs in caveolae traffic to the nucleus. Intracellular movement of the receptor will be monitored by as well as by cell fractionation studies. Pathways identified in liver cells will be tested in cells derived from breast, lung, prostate, and colon cancers. 2. Whether and how EGF increases Ca2+ in the nucleus will be determined. Targeted InsP3 buffers will be used to determine whether EGF, like HGF, specifically induces InsP3 formation within the nucleus. RNA interference techniques will be used to compare PLC isoforms activated by EGF and HGF, and to determine whether these PLC isoforms vary among cell types. 3. The role of nuclear Ca2+ signals in EGF-induced cell growth will be determined. We will determine whether EGF-induced cell proliferation is disrupted by blocking either (a) movement of EGFR to the nucleus, (b) EGF-induced formation Ca2+ signals in the nucleus, or (c) activation of Ca2+-dependent proteins within the nucleus, such as CaMKII. These studies will reveal how growth factors and their corresponding receptor tyrosine kinases control nuclear Ca2+ in intact cells, and identify the distinct role this may play in regulating tumor growth. This research will be performed primarily at UFMG in Brazil in collaboration with Dawidson Gomes as an extension of Project 1 of NIH P01 DK57751.

Public Health Relevance

Growth of cells within the liver and other organs is regulated by growth factors and their receptors, known as receptor tyrosine kinases. These studies will reveal how growth factors and their corresponding receptor tyrosine kinases control signaling within the cell nucleus, and identify the distinct role this signaling pathway may play in the abnormal growth that occurs in a wide variety of tumors.

National Institute of Health (NIH)
Fogarty International Center (FIC)
Small Research Grants (R03)
Project #
Application #
Study Section
International and Cooperative Projects - 1 Study Section (ICP1)
Program Officer
Katz, Flora N
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Internal Medicine/Medicine
Schools of Medicine
New Haven
United States
Zip Code
Kunrath-Lima, Marianna; de Miranda, Marcelo Coutinho; Ferreira, Andrea da Fonseca et al. (2018) Phospholipase C delta 4 (PLC?4) is a nuclear protein involved in cell proliferation and senescence in mesenchymal stromal stem cells. Cell Signal 49:59-67
Faraco, Camila Cristina Fraga; Faria, Jerusa Araújo Quintão Arantes; Kunrath-Lima, Marianna et al. (2018) Translocation of Epidermal Growth Factor (EGF) to the nucleus has distinct kinetics between adipose tissue-derived mesenchymal stem cells and a mesenchymal cancer cell lineage. J Struct Biol 202:61-69
Ferreira, Andrea da Fonseca; Cunha, Pricila da Silva; Carregal, Virgínia Mendes et al. (2017) Extracellular Vesicles from Adipose-Derived Mesenchymal Stem/Stromal Cells Accelerate Migration and Activate AKT Pathway in Human Keratinocytes and Fibroblasts Independently of miR-205 Activity. Stem Cells Int 2017:9841035
Rodrigues, Michele A; Gamba, Conrado O; Faria, Jerusa Araújo Quintão Arantes et al. (2016) Inner nuclear membrane localization of epidermal growth factor receptor (EGFR) in spontaneous canine model of invasive micropapillary carcinoma of the mammary gland. Pathol Res Pract 212:340-4
Faria, Jerusa A Q A; de Andrade, Carolina; Goes, Alfredo M et al. (2016) Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation. Biochem Biophys Res Commun 478:39-45
Oliveira, Mariana S; Mussi, Samuel V; Gomes, Dawidson A et al. (2016) ?-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles. Colloids Surf B Biointerfaces 140:246-253
Silva, Elton Luiz; Carneiro, Guilherme; Caetano, Priscila Albuquerque et al. (2015) Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid. Expert Rev Anticancer Ther 15:247-56
Paula, Ana C C; Martins, Thaís M M; Zonari, Alessandra et al. (2015) Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation. Stem Cell Res Ther 6:76
Pereira, Núbia Braga; do Carmo, Ana Carolina de Melo; Diniz, Marina Gonçalves et al. (2015) Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas. Oncotarget 6:9679-85
Dantas, Arthur Estanislau; Horta, Carolina Campolina Rebello; Martins, Thais M M et al. (2014) Whole venom of Loxosceles similis activates caspases-3, -6, -7, and -9 in human primary skin fibroblasts. Toxicon 84:56-64

Showing the most recent 10 out of 21 publications